Please ensure Javascript is enabled for purposes of website accessibility

Cabot Prime Pro Week Ending December 8, 2023

Latest Summary


Cabot Weekly Review (Video)

In this week’s video, Mike Cintolo is in the same boat as last week--the preponderance of intermediate-term evidence is bullish but there has been some short-term churning in the indexes. He goes into detail of what that means for his stance and reviews a ton of leading stocks (which continue to handle themselves well) he’s eyeing. Stocks Discussed: DDOG, NET, SHOP, LLY, NVDA, AZEK, GTLB, TMDX, ZS, S, VRT, DASH, MBLY

Cabot Street Check (Podcast)

This week on Street Check, Chris and Brad briefly talk AI in their daily lives before Chris and breaks down the bull case for Bitcoin after a triple-digit (percentage) run from 2023 lows. Then, they welcome on small-cap investing expert Tyler Laundon to discuss a crypto bet he lost to Jacob Mintz, recent trends in an undervalued sector of the market and seeing Rivian SUVs outside the ski slopes. To close out the episode, they debate the Fed’s path forward, expectations for the market, and the importance of identifying strong companies and not painting asset classes with a broad brush.

Cabot Webinar

Save the Date: Thursday, December 14 at 2:00 PM ET

#1 Investment Strategy for 2024: Your Key to Outperformance in Today’s Market

Sign up now.

Quarterly Cabot Analyst Meeting

The recording of the Cabot Prime Members Meeting with the Analysts from October 18, 2023 is now available for you to listen to at your convenience—click here for access. This private call with our analysts is one of your exclusive Cabot Prime Pro member benefits.


This table lists stocks bought or sold in the most recent Issues or Updates.

Portfolio Updates This Week

Cabot Growth Investor

Bi-weekly Issue November 30: From an intermediate-term perspective, the pieces continue to fall into place for the bulls--recently, our Two-Second Indicator has joined our trend-following indicator on the bullish side of the fence, while things like our Aggression Index and the trend in interest rates remain encouraging. Short-term, we are finally seeing some signs of churning in extended leaders, so we’re continuing to move gradually, picking our stocks and spots carefully. Last week, we did a little more buying in DUOL and started a position in ANET, and today we’re starting one more half-sized stake that will diversify the portfolio a bit.

Bi-weekly Update December 7: WHAT TO DO NOW: Continue to lean bullish, though keep an eye on things in the short term. Overall, our indicators look very good, so we’re aiming to put more money to work—but near-term, we are seeing a few warning signs, so we’re picking our spots and stocks carefully. On yesterday’s special bulletin we sold Noble (NE) and added another half position in PulteGroup (PHM), but tonight, we’ll stand pat and see how things go in the coming days. Our cash position is now 36%.

Cabot Top Ten Trader

Weekly Issue December 4: Most of the rubber-meets-the-road evidence is positive when it comes to the intermediate-term, that said, short-term, some wobbles and rotation are beginning to creep in—some growth areas (like chips) are weakening while the broad market (small-caps, etc.) are perking up, and after five weeks of strong gains, investor sentiment has gotten a bit comfortable. That doesn’t have us growing more cautious, and in fact, we’re bumping up our Market Monitor to a level 7—though we are still favoring moving gradually and picking your stocks and entry points carefully.

This week’s list has another nice collection of stocks, including everything from precious metals to chemicals to some powerful earnings gaps in the tech space. Our Top Pick is a tech infrastructure name that isn’t early in its run, but after a choppy three months, it appears ready for its next move.

Movers & Shakers December 8: It’s been a relatively quiet and mildly positive week for the major indexes, with most up less than 1% (though small caps have been a little stronger) following this morning’s jobs report. It’s a similar story with interest rates, which, despite a pop higher today, are unchanged to slightly higher on the week.

Cabot Options Trader and Cabot Options Trader Pro

Cabot Options Trader Pro Weekly Update

Cabot Options Trader Weekly Update

Cabot Value Investor

Monthly Issue December 5: Artificial intelligence-inspired investors are partying like it’s 1999. We’re finding attractive value elsewhere, in discarded industrials like our new Buy recommendation, CNH Industrial (CNHI).

Weekly Update November 28: The best poker players usually are stone-faced. That means that they show no emotions, make no unusual or unplanned moves, and most important, have no “tells.” A “tell” is any change in a player’s behavior, attitude or other actions that indicate the strength of the cards they hold in their hand. Common tells are changes in their chatter, eye contact, twitches and frequency of checking their hole cards.

Cabot Stock of the Week

Weekly Issue December 4: The market continues to thrive as we enter the final month of 2023 – and Cabot Stock of the Week stocks are thriving along with it! A pullback in the coming days and perhaps weeks would make sense on the heels of the market’s banner November, but the long- and intermediate-term trajectory appears up. The potential (likelihood?) that interest rates may have peaked is perhaps the biggest driving force behind the rally. And it’s a big catalyst propelling the stock that we’re adding today, a brand-new recommendation from Mike Cintolo in Cabot Growth Investor.

Cabot Explorer

Bi-weekly Issue December 7: Led by the Magnificent Seven, the S&P 500 is a bit overcooked at the moment. Small and mid-caps, on the other hand, are cheap - and appear poised for outperformance in the New Year. So today, we add a mid-cap life sciences company with high upside potential in an emerging area of biology.

Bi-weekly Update November 30: Many analysts now expect a “Goldilocks scenario,” with the economy growing nicely but not too fast. This would mean that the Fed does not need to worry about raising interest rates further to combat inflation. Good news for stocks.

I would like to clarify there are two reasons that I remove a stock as an Explorer recommendation. When I recommend a stock, I expect that it will deliver appreciation and dividends over the long haul unless I highlight that it is a more of a short-term trading opportunity.

Cabot Small-Cap Confidential

Monthly Issue December 7: This month we’re adding a small company that specializes in software that helps organizations train their employees and the partners they work with.

The company has a market cap of $1.5 billion, is growing revenue by about 25% and throws off a ton of cash relative to its size. Moreover, I rarely see this stock in the media, despite impressive growth and achievements. I think that’s about to change.

Weekly Update November 30: With the market on track to post a very nice gain in November, it’s been a good time to just sit back and let most stocks do their thing. Much of this move has been driven by lower yields and peak Fed chatter, with inflation and economic data largely supporting the disinflation and soft-landing scenario.

Whether or not the Fed will ultimately begin to cut rates next spring/early summer remains to be seen, but that’s what the market is currently expecting. We’ll now look to the December 12/13 FOMC meeting (last of the year) for Jerome Powell to repeat his “not thinking about thinking about cuts” shtick.

Cabot Dividend Investor

Monthly Issue November 8: The market has been highly unpredictable over the last several years. Things are too uncertain to make bets on the current outlook. Timing the market and betting on sector rotation is a riverboat gamble. I’d rather bank on prevailing trends that will transcend short-term market gyrations.

There is a strong prevailing positive trend in the energy industry, particularly American energy.

Clean energy is the future, but not the near future. The world will continue to rely overwhelmingly on fossil fuels for at least the rest of this decade and probably much longer. But the world has underinvested in oil and gas exploration and production over the last decade and a half. Global supplies are straining to meet growing demand. The dynamic will last for some time.

Investors are realizing the value of companies and stocks in a sector that had been neglected for many years until recently. While commodity prices will go up and down based on several circumstances, energy companies should benefit over time going forward.

In this issue, I highlight the largest American oil refiner. The stock has been a stellar performer. And the company will continue to benefit from cheaper American oil and a reduced number of refineries.

Weekly Update December 6: The superb rally that began after October is fading.

November was the best month for the S&P 500 in over a year. But now some reality is starting to set in. Wall Street took the good news about peak interest rates to another level and started pricing in Fed rate cuts early next year. The market is pulling back after the Fed dismissed that notion.

Cabot Early Opportunities

Monthly Issue November 15: In the November Issue of Cabot Early Opportunities we lean into the strengthening market with a group of companies doing everything from providing security for new AI applications to paving roads in the Sun Belt to making packaged foods for health-conscious consumers, and more.

Cabot Profit Booster

Weekly Issue December 5: The bulls once again pushed the market higher last week as the S&P 500 gained 0.77%, the Dow was the big winner with a rally of 2.42%, and the Nasdaq rose marginally by 0.38%.

Cabot Income Advisor

Monthly Issue November 21: There has been a dramatic turnaround in the market this month. After falling for three straight months, the S&P 500 has rallied 7.6% in the first three weeks of November. The main reason for the turnaround is interest rates. If the current Wall Street expectation that the benchmark 10-year Treasury rate peaked at 5% is true, it should be positive for stocks, or at least eliminate a big negative.

Weekly Update December 5: The market had a great November. But the rally petered out.

Wall Street always overdoes it. It took the good news about peak interest rates to another level and started pricing in Fed rate cuts early next year. The market pulled back on Monday because the Fed dismissed that notion.

Cabot Turnaround Letter

Monthly Issue November 29: Every investor has loser stocks. We discuss two ways to convert this year’s losers into assets and winners, including tax loss selling and buying shares that others have discarded for artificial reasons. Last year’s crop of bounce stocks performed exceptionally well. We discuss five for this year that look promising.

One of our more productive methods for sourcing new ideas is to see what other like-minded investors are buying. We discuss how to refine the vast data in 13F filings and review four from the most recent batch of filings that look attractive.

This month’s Buy recommendation, Fidelity National Information Services (FIS), was used in a February 2023 article about how we evaluate candidates. It was too expensive then, but its recent 26% share price slide and encouraging fundamentals make it attractive to buy now.

Weekly Update December 8: There were no earnings reports or ratings changes this week.

Cabot Cannabis Investor

Monthly Issue November 29: Cabot Cannabis Investor has delivered several excellent trades in the past month.

* Back on October 31 I was very bullish on the cannabis group which was weak because of the nomination of Rep. Mike Johnson (R-LA) as House speaker. He has always opposed cannabis legislation. I argued there were several other catalysts in the mix regardless of how Congress acted on legal reforms. “Cannabis stocks are a strong buy in the weakness,” I wrote.

I suggested any of the names in our portfolio, or the AdvisorShares Pure U.S. Cannabis (MSOS) exchange-traded fund (ETF) and the leveraged version, AdvisorShares MSOS 2x Daily (MSOX), for simplicity. “I am adding to MSOS and MSOX in the weakness, and I will continue to add, particularly if they get weaker from here.” Since October 31, here’s how those trades have done.

Monthly Update November 8: Cannabis stocks are up 10%-20% since I encouraged you to buy them on weakness in my last update on October 31.

That’s a nice short-term gain – much better than the 5.5% S&P 500 advance over the same time.

I hope you participated.

Traders may want to book profits. The stocks are strong this morning on news that Ohio voters approved a referendum on recreational use legalization. This rally could reverse. However, cannabis stocks are still down sharply from the rescheduling rally last summer. I suggest continuing to stay long in the midst of the overall weakness since that rescheduling news rally last summer.

Cabot Money Club

Monthly Magazine December: The end of the year is a time for friends, family, holidays, and celebrations of all stripes. It’s also (unfortunately) a time to do some year-end clean up of your portfolio, harvest some tax losses, and get started on planning for 2024. So, to give you a head start before you have to meet your accountant, this month we’re exploring tax credits, including some you may have never heard of, and the most important numbers you need to know when planning for the year ahead. Plus, we’ll highlight some tax-efficient investments to save you money next year.

Stock of the Month November 9: The markets had a very good week, and so far, we are also seeing momentum in the first couple of trading days this week. These upward moves have taken the Dow Jones Industrial Average to just about where we started at the beginning of 2023.

Last month, inflation edged up to 3.7%, from 3.67%, and the unemployment rate also slightly increased, to 3.9%. The Federal Reserve—for two continuous decisions—kept the Fed Funds rate steady.

Ask the Experts

Prime Question for Mike: Mike, I’m weary of (often tech) companies that rely on hyper-growth rates to compensate for stock-based compensation. Bill.Com just reported a decent quarter but not as much of a surprise as usual and lowered revenue guidance from approximately 30% to 20% for the next year. Stock dropped. Lower, non-hyper growth of and stock based compensation don’t mix well. Although I love MongoDB’s (MDB) product (I’m a retired programmer) I just sold the stock because of their heavy reliance on stock-based compensation.

What I’ve started to look for is companies that will benefit from falling rates because they have debt or own bonds. The latter category is mostly insurance companies. I bought Everest Group (EG).

WillScot Mobile (WSC) has substantial growth, but the debt/total capital is about 60%. The method of operation is each year acquire a small company and usually add to debt, then use any excess cash to buy back stock. ... Interest expense is at an all-time high for them. Both they and the construction industry will benefit (from) lower rates.

Anyway, I’d like to see even more picks like PulteGroup (PHM), of companies that would benefit from lower rates and be warned of picks that rely on the hyper-growth/stock-based compensation combo. Thanks! I enjoy your growth service very much.

Mike: Thanks for writing and the kind words. I can’t argue with your logic – and maybe that’s one reason why we’re seeing more small caps and economically sensitive names perk up. We’re not huge on diving into the super-popular names right now, though we will go wherever the growth is. We’ll see, but I am trying to not have all chip/software/tech type names, per se.